NEW YORK (GenomeWeb) – LifeMap Sciences today announced an agreement to promote Toldot Genetics' products to its users in academia, research hospitals, and biopharmaceutical companies.

The partners also said they will collaborate to optimize Toldot's genetic variation analysis tools using LifeMap's GeneCards database.

LifeMap, a BioTime subsidiary, is the exclusive marketer of genetic database tools developed by the Weizmann Institute of Science in Rehovot, Israel, including the GeneCards human gene database and MalaCards human disease database.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.